SwissMedic-2021-0029-V229
Type IA variation for application SwissMedic-2021-0029. Type IA variation: Facility Change for Brextanib — major revision
Variation Number
SwissMedic-2021-0029-V229
Type
Type IA
Application
Change
Status
Draft
Fee
€4,509
Submitted
—
Approved
—
Description
Type IA variation: Facility Change for Brextanib — major revision